Vendor, Thousand Oaks, CA
Amgen Inc.
UEI D92HARF1LKA9, CAGE 0JVZ6
2 awards and $2,276,291 obligated between May 1, 2024 and June 2, 2026, 50% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $2,276,291 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $2,276,291 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Not Competed | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50119C00061Definitive Contract, May 1, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Modification to Revise the Pop Within Prism to Match Bilateral Modification Dates.NAICS 541714, PSC AN73 | $2,276,291 |
| 75A50123C00040Definitive Contract, June 2, 2026, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Extension Clin 0001. Period of Performance for Clin 0001 Ends 28 June 2028. Revise B.6 Advance Understandings and Revise Section G tNAICS 325412, PSC 6505 | $0 |
- Places of performance
- California
- Product and service codes
- AN73 N – Health R&D Services6505 Drugs and Biologicals
- Transactions
- 3 across 2 awards